1-3 of 3
Sarah Wiedemann
Close
Sort by
Journal Articles

Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors

Florian Moik, Jakob Riedl, Dominik Barth, Wei-Shin Evelyn Chan, Sarah Wiedemann, Christoph Höller, Thorsten Fuereder, Philipp Jost, Ingrid Pabinger, Matthias Preusser, Cihan Ay
Journal: Blood
Blood (2022) 140 (Supplement 1): 1250–1251.
https://doi.org/10.1182/blood-2022-160087
Published: 2022
Journal Articles

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Clinical Trials & Observations
Florian Moik, Wei-Shin Evelyn Chan, Sarah Wiedemann, Christoph Hoeller, Felix Tuchmann, Marie-Bernadette Aretin, Thorsten Fuereder, Sabine Zöchbauer-Müller, Matthias Preusser, Ingrid Pabinger, Cihan Ay
Journal: Blood
Blood (2021) 137 (12): 1669–1678.
https://doi.org/10.1182/blood.2020007878
Published: 2021
Includes: Supplemental data
Journal Articles

Biomarkers of Haemostasis and Occurrence of Venous Thromboembolism Are Associated with Disease Progression and Poor Prognosis in Patients with Pancreatic Cancer

Florian Moik, MD, Gerald Prager, MD, Sarah Wiedemann, Florian Posch, MD MSc, PhD, Ingrid Pabinger, MD, Cihan Ay, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-141239
Published: 2020